# Medicare: Stakeholders

## Who Is Affected

### Primary Stakeholders

| Group | Impact | Size |
|-------|--------|------|
| Seniors (65+) | Primary health coverage | 61 million |
| People with disabilities | Coverage after 24-month wait | 5 million |
| ESRD patients | Coverage for kidney failure | 1 million |
| Dual eligibles | Medicare + Medicaid coverage | 12.4 million |
| Near-elderly (55-64) | Potential beneficiaries of expansion | 40 million |
| Future retirees | Depend on program solvency | 100+ million |

### Secondary Stakeholders

**Healthcare Providers**

- Hospitals: Medicare is largest revenue source (~30% of revenue)
- Physicians: Complex relationship; some limit Medicare patients
- Skilled nursing facilities: Heavily dependent on Medicare payment
- Home health agencies: Medicare dominates market
- Hospice providers: Almost entirely Medicare-funded

**Insurance Industry**

- Medicare Advantage plans: $450+ billion annual revenue
- Part D plan sponsors: Major business line
- Medigap insurers: Supplement traditional Medicare
- Pharmacy Benefit Managers: Process Part D claims

**Pharmaceutical Industry**

- Medicare Part D: Major revenue source
- Protected pricing (until IRA): Premium prices for seniors
- Facing negotiation: New price pressure beginning

**Taxpayers**

- General revenue funds 75% of Part B
- Trust Fund depletion affects all taxpayers
- Medicare spending drives federal deficit

## Who Has Power

### Decision Makers

- **Congress**: Sets benefits, eligibility, financing, payment rules
- **CMS (Centers for Medicare & Medicaid Services)**: Administers program, sets payment rates, regulates MA plans
- **HHS Secretary**: Policy direction, regulatory priorities
- **MedPAC (Medicare Payment Advisory Commission)**: Influential advisory body
- **CMMI (Center for Medicare & Medicaid Innovation)**: Tests new payment models

### Key Congressional Actors

| Committee | Role |
|-----------|------|
| Senate Finance | Medicare legislation, oversight |
| House Ways and Means | Medicare legislation, oversight |
| House Energy and Commerce | Shared jurisdiction |
| Budget Committees | Reconciliation instructions |
| Appropriations | Discretionary administrative funding |

### Influencers

| Actor | Influence | Position |
|-------|-----------|----------|
| AARP | 38 million members; lobbying powerhouse | Protect benefits; cautious on reform |
| Medicare Rights Center | Beneficiary advocacy | Expand benefits; regulate MA |
| AMA | Physician payment; policy influence | Increase physician payment; limit administrative burden |
| AHA (American Hospital Association) | Hospital payment; policy | Maintain/increase hospital payments |
| AHIP (America's Health Insurance Plans) | Insurance industry trade group | Protect MA payments and structure |
| PhRMA | Pharmaceutical industry | Oppose price negotiation; protect Part D |
| Better Medicare Alliance | MA advocacy coalition | Protect and expand MA |
| Physicians for a National Health Program | Single-payer advocacy | Medicare for All |

## Stakeholder Interests

### Beneficiary Perspectives

| Concern | Affected Population |
|---------|---------------------|
| Premium affordability | Lower-income beneficiaries |
| Out-of-pocket caps | Those with chronic conditions |
| Drug prices | All beneficiaries (especially Part D enrollees) |
| Benefit gaps (dental, vision, hearing) | All traditional Medicare enrollees |
| MA network restrictions | MA enrollees needing out-of-network care |
| Provider access | Rural beneficiaries; those needing specialists |
| Program solvency | All current and future beneficiaries |

### Provider Perspectives

| Concern | Position |
|---------|----------|
| Payment adequacy | Seek higher Medicare rates |
| Administrative burden | Reduce prior authorization, quality reporting |
| Value-based payment | Mixed; prefer flexibility |
| Site-neutral payment | Hospitals oppose; physicians divided |
| MA provider contracts | Seek fair terms, prompt payment |

### Insurer Perspectives

| Concern | Position |
|---------|----------|
| MA payment rates | Maintain or increase benchmark payments |
| Risk adjustment | Preserve current methodology |
| Star ratings | Resist tightening quality standards |
| Prior authorization | Maintain flexibility for utilization management |
| Part D negotiations | Minimize impact of IRA provisions |

### Positions on Key Reforms

| Stakeholder | Expansion (age/eligibility) | Benefit Expansion | MA Oversight | Drug Negotiation |
|-------------|----------------------------|-------------------|--------------|------------------|
| Beneficiaries | Support | Strongly support | Support | Strongly support |
| Hospitals | Cautious support | Support | Neutral | Support |
| Physicians | Divided | Support | Support | Support |
| MA plans | Oppose | Oppose (traditional) | Oppose | Oppose/accept |
| PhRMA | Oppose | Neutral | Neutral | Strongly oppose |
| AARP | Cautious support | Support | Support | Support |
| Conservatives | Oppose | Oppose | Neutral/support | Divided |

---

## Document Navigation

- Previous: [Root Causes](04-root-causes.md)
- Next: [Opposition](06-opposition.md)
